Abstract
The invention concerns a compound of formula I, a pharmaceutical formulation comprising the compound of formula I and use of the pharmaceutical composition for treating inflammatory or diabetic disease.
Originalsprog | Engelsk |
---|---|
IPC | A61K31/44,A61P25/00,A61P29/00,C07D213/69,C07D405/12 |
Patentnummer | WO 2021/123394 A1 |
Journaliseringsdato | 18/12/2020 |
Land/Område | Danmark |
Prioritetsdato | 20/12/2019 |
Prioritetsnummer | EP20150090A |
Status | Udgivet - 2021 |